Latest news with #specialtychemicals
Yahoo
4 days ago
- Business
- Yahoo
IMCD appoints Andreas Igerl to lead EMEA region and global Industrial Business Groups, and Narendra Varde to lead APAC region
Rotterdam, The Netherlands (16 July 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, announces the appointment of Andreas Igerl as Regional President Europe, Middle East & Africa (EMEA) as of 1 September 2025, and as Leader of the global Industrial Business Groups, with effect progressively over the course of 2025. Narendra Varde is appointed as Regional President Asia-Pacific (APAC), succeeding Andreas Igerl, effective 1 September 2025. Andreas Igerl to drive execution and focus across EMEA and global Industrial Business Groups Andreas Igerl is currently Regional President APAC and a member of the IMCD Executive Committee. Under his leadership, APAC has seen strong performance, successful execution of strategic initiatives, and greater cross-team integration. As Regional President EMEA, he will take on the responsibility to accelerate growth in EMEA and further strengthening regional coordination and the rollout of best practices, digital tools, and commercial and operational excellence programmes. The new EMEA leadership is being established to support IMCD's growth and simplify execution across more than 30 countries in the region. In parallel, IMCD's global Industrial Business Groups' Directors will progressively come under the leadership of Andreas throughout 2025 to further support stronger strategic alignment, allow faster implementation of shared priorities and increase cross-fertilisation between markets. These changes reflect IMCD's continued focus on speed, efficiency and customer and supplier centricity as it grows across geographies and industries. Narendra Varde to lead APAC region From 1 September 2025, Narendra Varde, currently Managing Director India, is appointed as the new Regional President APAC, succeeding Andreas Igerl. He has delivered strong results in developing IMCD India, demonstrating a clear strategic approach and building high-performing teams. He brings valuable experience and leadership to his new role and will continue driving growth and execution across the APAC region. His successor as Managing Director India will be announced in due time. IMCD CEO Marcus Jordan said: 'Andreas Igerl and Narendra Varde are pragmatic leaders, with strong execution focus and a collaborative style. Their appointment to these key roles supports our aim to grow with speed, delivering exceptional service to our customers and suppliers, and keep strengthening how we work together across regions and Business Groups.' Andreas Igerl comments: 'I'm excited to take on this next chapter at IMCD. EMEA is a region which has always been incredibly important for IMCD and still has a huge potential. Bringing our Industrial Business Groups closer together gives us a great opportunity to accelerate collaboration and unlock new value across the markets we serve. I look forward to working with our teams and partners to make it happen.' Narendra Varde adds: 'I'm honoured to step into the role of Regional President APAC, and build on the strong momentum already in place. Together with our teams and partners across the region, I'm looking forward to driving impactful growth, staying deeply connected with our customers and suppliers, and pushing boundaries for a continued progress together.' - xxx- About IMCD IMCD, based in Rotterdam, The Netherlands, is a leading global partner for the distribution and formulation of speciality chemicals and ingredients. IMCD is an expert solutions provider and adds sustainable value to the supply chain. Every day professionals focus on providing the best service through commercial and operational excellence. The company is mindful of the role they play in creating a better planet for all and formulates with consciousness and executes with care, to address business challenges of tomorrow, in partnership and transparency. In 2024, with over 5,100 employees, IMCD realised revenues of EUR 4,728 million. IMCD N.V.'s shares are traded at Euronext Amsterdam (symbol: IMCD) and included in the Dutch ESG AEX index, as one of 25 companies within the AEX and AMX indices demonstrating best ESG practices. For further information, please visit Media contact Muriel Werlé Corporate Communications Director+31 10 290 86 14 mediarelations@ Investor relations contact Tosca Holtland Head of Investor Relations+31 10 290 86 53ir@ Attachment PR IMCD appoints Andreas Igerl and Narendra VardeError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 days ago
- Business
- Yahoo
What You Need to Know Ahead of Albemarle's Earnings Release
Charlotte, North Carolina-based Albemarle Corporation (ALB) develops, manufactures, and markets engineered specialty chemicals for mobility, energy, connectivity, and health solutions. With a market cap of $8.4 billion, the company offers critical ingredients used in grid storage, automotive, aerospace, conventional energy, electronics, construction, agriculture and food, pharmaceuticals, and medical devices. The lithium giant is expected to announce its fiscal second-quarter earnings for 2025 after the market closes on Wednesday, Jul. 30. Ahead of the event, analysts expect ALB to report a loss of $0.84 per share on a diluted basis, down significantly from a profit of $0.04 per share in the year-ago quarter. The company missed the consensus estimates in three of the last four quarters while beating the forecast on another occasion. Shopify Stock is a Bargain - How to Make a 3.2% One-Month Yield with SHOP Tariffs, Inflation and Other Key Things to Watch this Week Stocks Set to Open Lower as Trump Ratchets Up Tariff Threats, U.S. Inflation Data and Big Bank Earnings Awaited Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. For the full year, analysts expect ALB to report a loss of $1.87 per share, up 20.1% from $2.34 per share in fiscal 2024. Meanwhile, its EPS is expected to rise 136.4% year over year to $0.68 in fiscal 2026. ALB stock has considerably underperformed the S&P 500 Index's ($SPX) 12.1% gains over the past 52 weeks, with shares down 27.5% during this period. Similarly, it significantly underperformed the Materials Select Sector SPDR Fund's (XLB) 2.1% gains over the same time frame. The primary reasons for ALB's underperformance are related to decreased pricing in its energy storage segment and reduced volumes in its Ketjen segment. These challenges have been further exacerbated by the unpredictable fluctuations in global trade policies under President Trump's administration, leading to increased volatility and uncertainty for the company. On Apr. 30, ALB shares closed down by 1.5% after reporting its Q1 results. Its revenue stood at $1.1 billion, down 20.9% year over year. The company's adjusted loss per share came in at $0.18, down 169.2% year over year. Analysts' consensus opinion on ALB stock is reasonably bullish, with a 'Moderate Buy' rating overall. Out of 24 analysts covering the stock, seven advise a 'Strong Buy' rating, two suggest a 'Moderate Buy,' 13 give a 'Hold,' and two recommend a 'Strong Sell.' ALB's average analyst price target is $78.92, indicating a potential upside of 11.2% from the current levels. On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12-07-2025
- Business
- Yahoo
Albemarle (ALB) Dips More Than Broader Market: What You Should Know
Albemarle (ALB) closed at $70.98 in the latest trading session, marking a -4.43% move from the prior day. This change lagged the S&P 500's daily loss of 0.33%. Meanwhile, the Dow experienced a drop of 0.63%, and the technology-dominated Nasdaq saw a decrease of 0.22%. Coming into today, shares of the specialty chemicals company had gained 18.87% in the past month. In that same time, the Basic Materials sector gained 1.87%, while the S&P 500 gained 4.07%. The investment community will be paying close attention to the earnings performance of Albemarle in its upcoming release. The company is slated to reveal its earnings on July 30, 2025. On that day, Albemarle is projected to report earnings of -$0.84 per share, which would represent a year-over-year decline of 2200%. Meanwhile, our latest consensus estimate is calling for revenue of $1.23 billion, down 13.67% from the prior-year quarter. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$1.87 per share and revenue of $4.86 billion, indicating changes of +20.09% and -9.54%, respectively, compared to the previous year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the business outlook. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 17.6% lower. Albemarle presently features a Zacks Rank of #3 (Hold). The Chemical - Diversified industry is part of the Basic Materials sector. Currently, this industry holds a Zacks Industry Rank of 209, positioning it in the bottom 16% of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. You can find more information on all of these metrics, and much more, on Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Albemarle Corporation (ALB) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
09-07-2025
- Business
- Yahoo
Albermarle Corp. (ALB) Jumps 7.2% on Bullish Rating
Albermarle Corporation (NYSE:ALB) is one of . Albermarle Corp. rebounded by 7.21 percent on Tuesday to close at $70.22 apiece as investor sentiment was bolstered by an investment firm's bullish rating for its stock. In a market note, Jefferies reaffirmed its 'buy' recommendation for Albermarle Corporation (NYSE:ALB), but lowered its price target for its stock to $84 from $85 previously. Still, the new figure marked a 19.6-percent upside from its latest closing price. Meanwhile, Albermarle Corporation (NYSE:ALB) earned a more conservative 'Hold' recommendation from Zacks Research, on expectations that it would post sales of $1.21 billion for the current quarter or a -15 percent change year-on-year. A team of scientists in a laboratory observing the sophisticated engineering of specialty chemicals. Meanwhile, it sees the company recording $4.86 billion and $5.35 billion in sales for the current and next fiscal years indicating changes of -9.5 percent and +9.9 percent, respectively. Albermarle Corporation (NYSE:ALB) is a US-based specialty chemicals manufacturing company that serves various industries, including agriculture, automotive, aviation, building and construction, among others. While we acknowledge the potential of ALB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
08-07-2025
- Business
- Yahoo
Cabot Corporation to Announce Third Quarter 2025 Operating Results
BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) announced today that it will release operating results for the third quarter of fiscal 2025 on Monday, August 4, 2025, after market close. The Company will host a conference call and live webcast to review the third quarter results beginning at 8:00 am (ET) on Tuesday, August 5, 2025. The call will be webcast by Notified and may be accessed at Cabot's website at If you are unable to participate during the live webcast, the call and accompanying slide presentation will be archived on the Company's website at ABOUT CABOT CORPORATIONCabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides and aerogel. For more information on Cabot, please visit the company's website at Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in the press release regarding Cabot's business that are not historical facts are forward looking statements that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended September 30, Contact: Steve Delahunt Vice President, Treasurer & Investor Relations (617) 342-6255Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
